Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026)

Artivion (AORT) posted Liabilities and Shareholders Equity of $883.2 million for Q1 2026, little changed on a QoQ basis from $884.8 million in Q4 2025, and up 11.63% year-over-year from $791.2 million in Q1 2025.

Artivion (AORT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Artivion's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $883.2 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 11.63% year-over-year to $883.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 billion (up 9.17% YoY) and the FY2025 annual result came in at $884.8 million, up 12.13% from the prior year.
  • Liabilities and Shareholders Equity was $883.2 million for Q1 2026 at Artivion, roughly flat from $884.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $884.8 million in Q4 2025 and bottomed at $742.7 million in Q3 2022.
  • A 5-year average of $798.5 million and a median of $789.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 9.27% — and 2025, when it rose 12.13%.
  • Artivion's Liabilities and Shareholders Equity stood at $762.8 million in 2022, then advanced by 3.88% to $792.4 million in 2023, then declined by 0.42% to $789.1 million in 2024, then advanced by 12.13% to $884.8 million in 2025, then slipped by 0.19% to $883.2 million in 2026.
  • Business Quant data shows AORT's Liabilities and Shareholders Equity at $883.2 million in Q1 2026, $884.8 million in Q4 2025, and $857.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Artivion 1.25 Bn 1.19 Bn 75.45 Mn 883.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 883.16 Mn
Dec 31, 2025 884.80 Mn
Sep 30, 2025 857.66 Mn
Jun 30, 2025 838.39 Mn
Mar 31, 2025 791.16 Mn
Dec 31, 2024 789.10 Mn
Sep 30, 2024 803.14 Mn
Jun 30, 2024 789.54 Mn
Mar 31, 2024 784.01 Mn
Dec 31, 2023 792.40 Mn
Sep 30, 2023 774.79 Mn
Jun 30, 2023 777.86 Mn
Mar 31, 2023 757.07 Mn
Dec 31, 2022 762.80 Mn
Sep 30, 2022 742.73 Mn
Jun 30, 2022 764.86 Mn
Mar 31, 2022 781.86 Mn
Dec 31, 2021 793.05 Mn
Sep 30, 2021 818.65 Mn
Jun 30, 2021 810.50 Mn